Terms: = Pancreatic cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Treatment
22 results:
1. Machine learning algorithm integrates bulk and single-cell transcriptome sequencing to reveal immune-related personalized therapy prediction features for pancreatic cancer.
Zang L; Zhang B; Zhou Y; Zhang F; Tian X; Tian Z; Chen D; Miao Q
Aging (Albany NY); 2023 Dec; 15(23):14109-14140. PubMed ID: 38095640
[TBL] [Abstract] [Full Text] [Related]
2. BUB1 Is Identified as a Potential Therapeutic Target for pancreatic cancer treatment.
Li M; Duan X; Xiao Y; Yuan M; Zhao Z; Cui X; Wu D; Shi J
Front Public Health; 2022; 10():900853. PubMed ID: 35769782
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell RNA-seq reveals the genesis and heterogeneity of tumor microenvironment in pancreatic undifferentiated carcinoma with osteoclast-like giant-cells.
Wang X; Miao J; Wang S; Shen R; Zhang S; Tian Y; Li M; Zhu D; Yao A; Bao W; Zhang Q; Tang X; Wang X; Li J
Mol Cancer; 2022 Jun; 21(1):133. PubMed ID: 35733218
[TBL] [Abstract] [Full Text] [Related]
4. Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements.
Schram AM; Odintsov I; Espinosa-Cotton M; Khodos I; Sisso WJ; Mattar MS; Lui AJW; Vojnic M; Shameem SH; Chauhan T; Torrisi J; Ford J; O'Connor MN; Geuijen CAW; Schackmann RCJ; Lammerts van Bueren JJ; Wasserman E; de Stanchina E; O'Reilly EM; Ladanyi M; Drilon A; Somwar R
Cancer Discov; 2022 May; 12(5):1233-1247. PubMed ID: 35135829
[TBL] [Abstract] [Full Text] [Related]
5. Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer.
Liu Z; Guo C; Dang Q; Wang L; Liu L; Weng S; Xu H; Lu T; Sun Z; Han X
EBioMedicine; 2022 Jan; 75():103750. PubMed ID: 34922323
[TBL] [Abstract] [Full Text] [Related]
6. Health care utilization at end of life among patients with lung or pancreatic cancer. Comparison between two Swedish cohorts.
Ullgren H; Fransson P; Olofsson A; Segersvärd R; Sharp L
PLoS One; 2021; 16(7):e0254673. PubMed ID: 34270589
[TBL] [Abstract] [Full Text] [Related]
7. Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database.
Ptáková N; Martínek P; Holubec L; Janovský V; Vančurová J; Grossmann P; Navarro PA; Rodriguez Moreno JF; Alaghehbandan R; Hes O; Májek O; Pešek M; Michal M; Ondič O
Genes Chromosomes Cancer; 2021 Jul; 60(7):474-481. PubMed ID: 33583086
[TBL] [Abstract] [Full Text] [Related]
8. An iodine-125 seed strand combined with a metal stent versus a metal stent alone for obstructive jaundice caused by pancreatic ductal adenocarcinoma.
Li J; Yu T; Zhang L; Yang M; Gao S; Pu N; Li C; Wang C; Gong G; Cheng J; Wang L; Li G; Wang X; Chen Y
Brachytherapy; 2021; 20(2):446-453. PubMed ID: 33309002
[TBL] [Abstract] [Full Text] [Related]
9. NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents.
Laskin J; Liu SV; Tolba K; Heining C; Schlenk RF; Cheema P; Cadranel J; Jones MR; Drilon A; Cseh A; Gyorffy S; Solca F; Duruisseaux M
Ann Oncol; 2020 Dec; 31(12):1693-1703. PubMed ID: 32916265
[TBL] [Abstract] [Full Text] [Related]
10. Risk of primary gastrointestinal cancers following incident non-metastatic breast cancer: a Danish population-based cohort study.
Adelborg K; Farkas DK; Sundbøll J; Schapira L; Tamang S; Cullen MR; Cronin-Fenton D; Sørensen HT
BMJ Open Gastroenterol; 2020 Jun; 7(1):. PubMed ID: 32611556
[TBL] [Abstract] [Full Text] [Related]
11. Enhancing the Potency and Specificity of Engineered T Cells for cancer treatment.
Sukumaran S; Watanabe N; Bajgain P; Raja K; Mohammed S; Fisher WE; Brenner MK; Leen AM; Vera JF
Cancer Discov; 2018 Aug; 8(8):972-987. PubMed ID: 29880586
[TBL] [Abstract] [Full Text] [Related]
12. Is Neoadjuvant Therapy Sufficient in Resected pancreatic cancer Patients? A National Study.
de Geus SWL; Kasumova GG; Eskander MF; Ng SC; Kent TS; James Moser A; Vahrmeijer AL; Callery MP; Tseng JF
J Gastrointest Surg; 2018 Feb; 22(2):214-225. PubMed ID: 29235000
[TBL] [Abstract] [Full Text] [Related]
13. Prevalence and initial prescription of psychotropics in patients with common cancers in Japan, based on a nationwide health insurance claims database.
Sato I; Onishi H; Yamada S; Kawakami K
Psychooncology; 2018 Feb; 27(2):450-457. PubMed ID: 28750146
[TBL] [Abstract] [Full Text] [Related]
14. Preoperative defining system for pancreatic head cancer considering surgical resection.
Yang SJ; Hwang HK; Kang CM; Lee WJ
World J Gastroenterol; 2016 Jul; 22(26):6076-82. PubMed ID: 27468199
[TBL] [Abstract] [Full Text] [Related]
15. Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.
Azoulay L; Filion KB; Platt RW; Dahl M; Dormuth CR; Clemens KK; Durand M; Juurlink DN; Targownik LE; Turin TC; Paterson JM; Ernst P;
BMJ; 2016 Feb; 352():i581. PubMed ID: 26888382
[TBL] [Abstract] [Full Text] [Related]
16. Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer.
Ciliberto D; Staropoli N; Chiellino S; Botta C; Tassone P; Tagliaferri P
Pancreatology; 2016; 16(2):249-58. PubMed ID: 26852170
[TBL] [Abstract] [Full Text] [Related]
17. Milatuzumab-SN-38 conjugates for the treatment of cd74+ cancers.
Govindan SV; Cardillo TM; Sharkey RM; Tat F; Gold DV; Goldenberg DM
Mol Cancer Ther; 2013 Jun; 12(6):968-78. PubMed ID: 23427296
[TBL] [Abstract] [Full Text] [Related]
18. [Survival analysis of patients with spontaneous rupture of hepatocellular carcinoma].
Zhao GG; Xu W; Tian YH; Li DX
Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):838-42. PubMed ID: 23206303
[TBL] [Abstract] [Full Text] [Related]
19. Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry.
Worni M; Akushevich I; Gloor B; Scarborough J; Chino JP; Jacobs DO; Hahn SM; Clary BM; Pietrobon R; Shah A
Ann Surg Oncol; 2012 Apr; 19(4):1316-23. PubMed ID: 22002799
[TBL] [Abstract] [Full Text] [Related]
20. cd74 is a novel prognostic factor for patients with pancreatic cancer receiving multimodal therapy.
Nagata S; Jin YF; Yoshizato K; Tomoeda M; Song M; Iizuka N; Kitamura M; Takahashi H; Eguchi H; Ohigashi H; Ishikawa O; Tomita Y
Ann Surg Oncol; 2009 Sep; 16(9):2531-8. PubMed ID: 19499276
[TBL] [Abstract] [Full Text] [Related]
[Next]